Jinyu Bio-Technology Co

Jinyu Bio-Technology Co Forward P/E

The Forward P/E Ratio of Jinyu Bio-Technology Co (600201.SS) as of Oct 27, 2026 is 171.04. In the previous year, Forward P/E Ratio was 157.12 — a change of 8.86% (higher).

Forward P/E

171.04

YoY

8.86%

Last updated:

Forward P/E Ratio of Jinyu Bio-Technology Co is 2025 171.04 . Forward P/E Ratio of Jinyu Bio-Technology Co was 2024 157.12 . It decreases by 8.86% higher compared to the previous year.

The Jinyu Bio-Technology Co Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
22.70 CNY
Jan 1, 2019
77.47 CNY
Jan 1, 2020
42.16 CNY
Jan 1, 2021
44.79 CNY
Jan 1, 2022
81.28 CNY
Jan 1, 2023
60.37 CNY
Jan 1, 2024
157.12 CNY
Jan 1, 2025
171.04 CNY
The Jinyu Bio-Technology Co Forward P/E history
YEARForward P/EYoY
171.04+8.86%
157.12+160.25%
60.37-25.73%
81.28+81.47%
44.79+6.25%
42.16-45.58%
77.47+241.32%
22.70+15.33%
19.68-25.92%
26.57-25.57%
35.69-15.72%
42.35—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jinyu Bio-Technology Co Stock analysis

What does Jinyu Bio-Technology Co do? Jinyu Bio-Technology Co., Ltd. generates revenue by researching, developing, producing, and selling veterinary biological products, with a primary focus on veterinary vaccines. The company operates from its headquarters in Hohhot, Neimenggu, where it employs 1,618 full-time staff members to support these core activities. In addition to its main veterinary operations, the firm diversifies its income streams by engaging in textile processing, providing energy products, and offering property leasing and management activities. These supplementary services allow the company to serve various market segments beyond the veterinary sector. The business model relies on the direct sale of its veterinary vaccines and biological products to customers in the animal health industry. By integrating manufacturing with research and development, Jinyu Bio-Technology Co., Ltd. maintains control over its product quality and supply chain while expanding into related industrial and service areas. Jinyu Bio-Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jinyu Bio-Technology Co stock

Forward P/E Ratio of Jinyu Bio-Technology Co is 171.04 in 2025.

Forward P/E Ratio of Jinyu Bio-Technology Co changed from 157.12 to 171.04, representing a 8.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Jinyu Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Jinyu Bio-Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Jinyu Bio-Technology Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Jinyu Bio-Technology Co